Intrauterine Contraceptive Device (IUD) Placement at Time of C-Section
Acceptability and Technical Feasibility of Insertion of a Copper IUD at Time of Elective C-section: A Pilot Study
1 other identifier
interventional
7
1 country
1
Brief Summary
This is a pilot study of up to 10 women, which will test the hypothesis that the placement of copper IUDs through the uterine incision at the time of uncomplicated elective C-section is technically feasible and acceptable to women seeking long-term contraception.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_4
Started Nov 2007
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2007
CompletedFirst Submitted
Initial submission to the registry
August 11, 2008
CompletedFirst Posted
Study publicly available on registry
August 13, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2008
CompletedResults Posted
Study results publicly available
August 11, 2014
CompletedAugust 11, 2014
July 1, 2014
10 months
August 11, 2008
October 8, 2013
July 16, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Successful Retention of IUD
6 weeks
Secondary Outcomes (1)
Visibility Within the Vagina of IUD Strings at All Times.
At 3 days, 2 weeks and 6 weeks postpartum
Study Arms (1)
Copper IUD
EXPERIMENTALCopper IUD
Interventions
Intraoperative placement of copper IUD at time of C-section
Eligibility Criteria
You may qualify if:
- Pregnant woman
- Requires elective C-section
- Desires long-term contraception
You may not qualify if:
- Contraindications to copper IUD
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Los Angeles BRI
Torrance, California, 90502, United States
Limitations and Caveats
Pilot study involving only seven subjects, which limits generalizability of findings.
Results Point of Contact
- Title
- Dr. Anita Nelson
- Organization
- LA BioMed
Study Officials
- PRINCIPAL INVESTIGATOR
Anita L Nelson, MD
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 11, 2008
First Posted
August 13, 2008
Study Start
November 1, 2007
Primary Completion
September 1, 2008
Study Completion
September 1, 2008
Last Updated
August 11, 2014
Results First Posted
August 11, 2014
Record last verified: 2014-07